Identification of genetic risk factors for atherosclerosis and drug response markers using clinical trials of the cholesterol-lowering drug pravastatin

被引：0
|
作者：
Ranade, K
Squibb, BM
Iakoubova, OA
Devlin, JJ
Kirchgessner, TG
Tsuchihashi, Z
Ploughman, LM
Zerba, KE
Squibb, BM
Packard, CJ
Shepherd, JJ
Sacks, FM
Sabatine, MS
Braunwald, E
White, TE
Gregg, RE
Dracopoli, NC
Shaw, PM
Squibb, BM
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
[2] Celera Diagnost, Alameda, CA USA
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland
[5] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2962
引用
收藏
页码：642 / 642
页数：1
相关论文
共 50 条
  • [31] KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly
    Akao, Hironobu
    Polisecki, Eliana
    Kajinami, Kouji
    Trompet, Stella
    Robertson, Michele
    Ford, Ian
    Jukema, J. Wouter
    de Craen, Anton J. M.
    Westendorp, Rudi G. J.
    Shepherd, James
    Packard, Christopher
    Buckley, Brendan M.
    Schaefer, Ernst J.
    ATHEROSCLEROSIS, 2012, 220 (02) : 456 - 462
  • [32] IDENTIFICATION OF INCREASED SERUM CONCENTRATIONS OF LINEZOLID IN PATIENTS WITH COMMON PREDISPOSING RISK FACTORS FOR ADVERSE DRUG REACTION BY SYNERGISTIC USE OF CLINICAL PHARMACOLOGICAL WARD ROUNDS AND THERAPEUTIC DRUG MONITORING (TDM)
    Troeger, U.
    Reiche, I.
    Postel, S. C.
    Bode-Boeger, S. M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 : 7 - 7
  • [33] Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate
    Lucia Davila-Fajardo, Cristina
    Swen, Jesse J.
    Cabeza Barrera, Jose
    Guchelaar, Henk-Jan
    PHARMACOGENOMICS, 2013, 14 (01) : 63 - 73
  • [34] Relationship between patient risk and the clinical benefit of using drug-eluting stents. Metaregression from 31 randomized trials
    Moreno, Raul
    Rivero, Fernando
    Sanchez-Recalde, Angel
    Galeote, Guillermo
    Calvo, Luis
    Jimenez-Valero, Santiago
    Martinez-Peredo, Carlos
    Navas, Miguel A.
    Lopez-Sendon, Jose L.
    CIRCULATION, 2007, 116 (16) : 464 - 464
  • [35] Clinical Features, Risk Factors, and Prognostic Markers of Drug-Induced Liver Injury in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
    Zhang, Zhibin
    Li, Sisi
    Zhang, Zhixiong
    Yu, Kaihui
    Duan, Xunxin
    Long, Lin
    Zhang, Shulan
    Jiang, Meiying
    Liu, Ougen
    INDIAN JOURNAL OF DERMATOLOGY, 2020, 65 (04) : 274 - 278
  • [36] Genome-Wide Association Study of Bronchodilator Drug Response (BDR) in Minority Children with Asthma Provides Insights into Its Genetic Risk Factors
    Joo, J.
    Mak, A. C. Y.
    Xiao, S.
    Sleiman, P.
    Hu, D.
    Huntsman, S.
    Eng, C.
    Kan, M.
    Diwadkar, A.
    Hakonarson, H.
    Williams, L. K.
    Burchard, E. G.
    Himes, B. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [37] Identification of Risk Factors Associated with drug-induced Hypotension Among Hospitalized Patients. A Predictive Model Using Electronic Medical Records
    Soria-Saucedo, Rene
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 612 - 613
  • [38] Identification of Risk Factors Associated with Drug-Induced Severe Hypoglycemia Among Hospitalized Patients. A Predictive Model Using Electronic Medical Records
    Soria-Saucedo, Rene
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 613 - 613
  • [39] Genetic Risk Factors for Erectile Dysfunction and Genetic Determinants of Drug Response – on the Way to Improve Drug Safety?Genetische Risikofaktoren für die erektile Dysfunktion und genetische Determinanten der Therapieantwort – auf dem Wege zur Verbesserung der Medikamentensicherheit?
    Andreas Eisenhardt
    Winfried Siffert
    Herz, 2003, 28 (4) : 304 - 313
  • [40] Identifying the genetic risk factors for treatment response to lurasidone by genome-wide association study: A meta-analysis of samples from three independent clinical trials
    Li, Jiang
    Loebel, Antony
    Meltzer, Herbert Y.
    SCHIZOPHRENIA RESEARCH, 2018, 199 : 203 - 213
12345